BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reuter NP, Woodall CE, Scoggins CR, Mcmasters KM, Martin RCG. Radiofrequency Ablation vs. Resection for Hepatic Colorectal Metastasis: Therapeutically Equivalent? J Gastrointest Surg 2009;13:486-91. [DOI: 10.1007/s11605-008-0727-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Patel N, King A, Breen D. Imaging appearances at follow-up after image-guided solid-organ abdominal tumour ablation. Clinical Radiology 2017;72:680-90. [DOI: 10.1016/j.crad.2017.01.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
2 Qin S, Liu GJ, Huang M, Huang J, Luo Y, Wen Y, Wang Y, Chen L. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center. Int J Hyperthermia 2019;36:36-43. [PMID: 30489175 DOI: 10.1080/02656736.2018.1528511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
3 Peng S, Huang P, Yu H, Wen Y, Luo Y, Wang X, Zhou J, Qin S, Li T, Chen Y, Liu G, Huang M. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance. Medicine (Baltimore) 2018;97:e0044. [PMID: 29517661 DOI: 10.1097/MD.0000000000010044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jin M, Yu Q, Liu Y, Xu W, Fu X, Ji B. Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysis. J Clin Transl Hepatol 2021;9:149-59. [PMID: 34007796 DOI: 10.14218/JCTH.2020.00125] [Reference Citation Analysis]
5 Piltch A, Zhang F, Hayashi J. Culture and characterization of thymic epithelium from autoimmune NZB and NZB/W mice. Cell Immunol 1990;131:325-37. [PMID: 2242501 DOI: 10.1016/0008-8749(90)90258-s] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
6 Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 2013;7:1-6. [PMID: 23422905 DOI: 10.5009/gnl.2013.7.1.1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
7 Jang KU, Kim CW, Kim KH, Lim SB, Yu CS, Kim TW, Kim PN, Kim JH, Kim JC. Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases. Ann Coloproctol 2016;32:92-100. [PMID: 27437390 DOI: 10.3393/ac.2016.32.3.92] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
8 Yang PC, Lin BR, Chen YC, Lin YL, Lai HS, Huang KW, Liang JT. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer. Medicine (Baltimore) 2016;95:e3338. [PMID: 27057913 DOI: 10.1097/MD.0000000000003338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
9 Han Y, Yan D, Xu F, Li X, Cai JQ. Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis. Chin Med J (Engl) 2016;129:2983-90. [PMID: 27958231 DOI: 10.4103/0366-6999.195470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
10 Tagami T, Ernsting MJ, Li S. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. Journal of Controlled Release 2011;154:290-7. [DOI: 10.1016/j.jconrel.2011.05.020] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 8.5] [Reference Citation Analysis]
11 Wu YZ, Li B, Wang T, Wang SJ, Zhou YM. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: A meta-analysis. World J Gastroenterol 2011; 17(36): 4143-4148 [PMID: 22039331 DOI: 10.3748/wjg.v17.i36.4143] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
12 Diaz-nieto R, Fenwick S, Malik H, Poston G. Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence. Curr Treat Options in Oncol 2017;18. [DOI: 10.1007/s11864-017-0452-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
13 Dong Y, Wang WP, Mao F, Ji ZB, Huang BJ. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound. J Gastroenterol Hepatol. 2016;31:822-828. [PMID: 26480287 DOI: 10.1111/jgh.13202] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
14 Takeda A, Sanuki N, Kunieda E. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer. World J Gastroenterol 2014; 20(15): 4220-4229 [PMID: 24764660 DOI: 10.3748/wjg.v20.i15.4220] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
15 Valls C, Ramos E, Leiva D, Ruiz S, Martinez L, Rafecas A. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy. Scand J Surg. 2014;Epub ahead of print. [PMID: 25332220 DOI: 10.1177/1457496914553147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
16 Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, Noya G, Abraha I. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317. [PMID: 22696357 DOI: 10.1002/14651858.cd006317.pub3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
17 Mariani A, Kwiecinski W, Pernot M, Balvay D, Tanter M, Clement O, Cuenod CA, Zinzindohoue F. Real time shear waves elastography monitoring of thermal ablation: in vivo evaluation in pig livers. J Surg Res 2014;188:37-43. [PMID: 24485877 DOI: 10.1016/j.jss.2013.12.024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
18 Byam J, Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RC. Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation? Ann Surg Oncol 2009;16:3064-9. [PMID: 19727957 DOI: 10.1245/s10434-009-0693-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
19 Xu J, Qin X, Wang J, Zhang S, Zhong Y, Ren L, Wei Y, Zeng S, Wan D, Zheng S; Society of Surgery; Chinese Medical Association; Committee of Colorectal Cancer, Chinese Anti-cancer Association. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol. 2011;137:1379-1396. [PMID: 21796415 DOI: 10.1007/s00432-011-0999-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
20 Dong Y, Wang W, Gan Y, Huang B, Ding H. Radiofrequency ablation guided by contrast-enhanced ultrasound for hepatic malignancies: Preliminary results. Clinical Radiology 2014;69:1129-35. [DOI: 10.1016/j.crad.2014.06.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
21 Schullian P, Johnston E, Laimer G, Scharll Y, Putzer D, Eberle G, Kolbitsch C, Amann A, Stättner S, Bale R. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence. HPB (Oxford) 2021:S1365-182X(21)01705-6. [PMID: 34887174 DOI: 10.1016/j.hpb.2021.11.010] [Reference Citation Analysis]
22 de Jong MC, van Vledder MG, Ribero D, Hubert C, Gigot JF, Choti MA, Schulick RD, Capussotti L, Dejong CH, Pawlik TM. Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis. J Gastrointest Surg 2011;15:336-44. [PMID: 21108017 DOI: 10.1007/s11605-010-1391-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
23 Meriggi F, Bertocchi P, Zaniboni A. Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg 2013; 5(5): 138-145 [PMID: 23710291 DOI: 10.4240/wjgs.v5.i5.138] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
24 Vogl TJ, Farshid P, Naguib NN, Darvishi A, Bazrafshan B, Mbalisike E, Burkhard T, Zangos S. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119:451-461. [PMID: 24894923 DOI: 10.1007/s11547-014-0415-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
25 Schullian P, Gertl A, Laimer G, Putzer D, Siebert U, Levy E, Bale R. Quality of life analysis after stereotactic radiofrequency ablation of liver tumors. Sci Rep 2020;10:12809. [PMID: 32732877 DOI: 10.1038/s41598-020-69331-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Kele PG, Van der Jagt EJ, Krabbe PF, de Jong KP. Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence. Int J Hepatol 2012;2012:870306. [PMID: 23320184 DOI: 10.1155/2012/870306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
27 Li D, Kang J, Golas BJ, Yeung VW, Madoff DC. Minimally invasive local therapies for liver cancer. Cancer Biol Med. 2014;11:217-236. [PMID: 25610708 DOI: 10.7497/j.issn.2095-3941.2014.04.001] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
28 Stintzing S, Grothe A, Hendrich S, Hoffmann RT, Heinemann V, Rentsch M, Fuerweger C, Muacevic A, Trumm CG. Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases. Acta Oncol. 2013;52:971-977. [PMID: 23409768 DOI: 10.3109/0284186x.2013.766362] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
29 Martin RC, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010;17:171-178. [PMID: 19707829 DOI: 10.1245/s10434-009-0686-z] [Cited by in Crossref: 235] [Cited by in F6Publishing: 191] [Article Influence: 18.1] [Reference Citation Analysis]
30 Kwok N, Lee SR, Arellano RS. Postloco-Regional Therapy Imaging of the Liver. Semin Roentgenol 2016;51:378-83. [PMID: 27743572 DOI: 10.1053/j.ro.2016.05.005] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Lee KH, Kim HO, Yoo CH, Son BH, Park YL, Cho YK, Kim H, Han WK. Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer. Korean J Gastroenterol. 2012;59:218-223. [PMID: 22460570 DOI: 10.4166/kjg.2012.59.3.218] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
32 Hong Y, Martin RCG. Personalizing Locoregional Therapy for Patients with Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep 2017;13:126-35. [DOI: 10.1007/s11888-017-0356-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Yang G, Wang G, Sun J, Xiong Y, Li W, Tang T, Li J. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies. Int J Surg 2021;87:105896. [PMID: 33588125 DOI: 10.1016/j.ijsu.2021.105896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Xu Q, Kobayashi S, Ye X, Meng X. Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma: a meta-analysis of 16,103 patients. Sci Rep. 2014;4:7252. [PMID: 25429732 DOI: 10.1038/srep07252] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 6.4] [Reference Citation Analysis]
35 Shin H, Kim CW, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival. ANZ J Surg 2019;89:61-7. [PMID: 30484933 DOI: 10.1111/ans.14933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
36 Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, Chen MH, Choi BI, de Baere T, Dupuy D. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013. Eur Radiol. 2015;25:3438-3454. [PMID: 25994193 DOI: 10.1007/s00330-015-3779-z] [Cited by in Crossref: 138] [Cited by in F6Publishing: 130] [Article Influence: 19.7] [Reference Citation Analysis]
37 Ko S, Jo H, Yun S, Park E, Kim S, Seo HI. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol 2014; 20(2): 525-531 [PMID: 24574721 DOI: 10.3748/wjg.v20.i2.525] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
38 Meijerink MR, Puijk RS, van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M, Heymans J, Frankema JS, de Jong KP, Richel DJ, Prevoo W, Vlayen J. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol. 2018;41:1189-1204. [PMID: 29666906 DOI: 10.1007/s00270-018-1959-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 15.8] [Reference Citation Analysis]
39 Kim H, Gill B, Beriwal S, Huq MS, Roberts MS, Smith KJ. Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver Metastases. International Journal of Radiation Oncology*Biology*Physics 2016;95:1175-83. [DOI: 10.1016/j.ijrobp.2016.02.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
40 Lee CW, Kim JH, Won HJ, Shin YM, Ko HK, Kim PN, Ryu MH. Percutaneous Radiofrequency Ablation of Hepatic Metastases from Gastric Adenocarcinoma after Gastrectomy. J Vasc Interv Radiol 2015;26:1172-9. [PMID: 26116362 DOI: 10.1016/j.jvir.2015.05.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
41 Lee H, Heo JS, Cho YB, Yun SH, Kim HC, Lee WY, Choi SH, Choi DW. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: A propensity score analysis. World J Gastroenterol 2015; 21(11): 3300-3307 [PMID: 25805937 DOI: 10.3748/wjg.v21.i11.3300] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
42 Nielsen K, van Tilborg AA, Meijerink MR, Macintosh MO, Zonderhuis BM, de Lange ES, Comans EF, Meijer S, van den Tol MP. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg 2013;37:1340-7. [PMID: 23494086 DOI: 10.1007/s00268-013-1997-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
43 Aliyev S, Agcaoglu O, Aksoy E, Taskin HE, Vogt D, Fung J, Siperstein A, Berber E. Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis. Surgery. 2013;154:556-562. [PMID: 23859307 DOI: 10.1016/j.surg.2013.03.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
44 Bhagat N, Reyes DK, Lin M, Kamel I, Pawlik TM, Frangakis C, Geschwind JF. Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury. Cardiovasc Intervent Radiol 2013;36:449-59. [PMID: 22722717 DOI: 10.1007/s00270-012-0424-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
45 Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M, Quan Z, Gong W. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7:e45493. [PMID: 23029051 DOI: 10.1371/journal.pone.0045493] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
46 Li D, Kang J, Madoff DC. Locally ablative therapies for primary and metastatic liver cancer. Expert Rev Anticancer Ther. 2014;14:931-945. [PMID: 24746315 DOI: 10.1586/14737140.2014.911091] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
47 Kron P, Linecker M, Jones RP, Toogood GJ, Clavien PA, Lodge JPA. Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature. Front Oncol. 2019;9:1052. [PMID: 31750233 DOI: 10.3389/fonc.2019.01052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
48 Kardassis D, Ntinas A, Miliaras D, Kofokotsios A, Papazisis K, Vrochides D. Patients with multiple synchronous colonic cancer hepatic metastases benefit from enrolment in a “liver first” approach protocol. World J Hepatol 2014; 6(7): 513-519 [PMID: 25068003 DOI: 10.4254/wjh.v6.i7.513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
49 Lee SR, Kilcoyne A, Kambadakone A, Arellano R. Interventional oncology: pictorial review of post-ablation imaging of liver and renal tumors. Abdom Radiol 2016;41:677-705. [DOI: 10.1007/s00261-016-0665-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
50 Govaert KM, van Kessel CS, Steller EJ, Emmink BL, Molenaar IQ, Kranenburg O, van Hillegersberg R, Borel Rinkes IH. Recurrence location after resection of colorectal liver metastases influences prognosis. J Gastrointest Surg 2014;18:952-60. [PMID: 24474631 DOI: 10.1007/s11605-014-2461-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
51 Schiffman SC, Reuter NP, McMasters KM, Scoggins CR, Martin RC. Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol. 2012;105:91-96. [PMID: 21815152 DOI: 10.1002/jso.22054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
52 Procopio F, Marano S, Gentile D, Da Roit A, Basato S, Riva P, De Vita F, Torzilli G, Castoro C. Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments. Cancers (Basel) 2019;12:E20. [PMID: 31861604 DOI: 10.3390/cancers12010020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
53 Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Nakajima TE, Sakamoto K, Hayano K, Mori Y, Asai K, Matsuyama R, Hirashita T, Hibi T, Sakai N, Tabata T, Kawakami H, Takeda H, Mizukami T, Ozaka M, Ueno M, Naito Y, Okano N, Ueno T, Hijioka S, Shikata S, Ukai T, Strasberg S, Sarr MG, Jagannath P, Hwang TL, Han HS, Yoon YS, Wang HJ, Luo SC, Adam R, Gimenez M, Scatton O, Oh DY, Takada T. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci 2021;28:1-25. [PMID: 33200538 DOI: 10.1002/jhbp.868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Gravante G, Overton J, Sorge R, Bhardwaj N, Metcalfe MS, Lloyd DM, Dennison AR. Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg. 2011;15:378-387. [PMID: 21061179 DOI: 10.1007/s11605-010-1377-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
55 Gotohda N, Nomura S, Doi M, Karasawa K, Ohki T, Shimizu Y, Inaba Y, Takeda A, Takaki H, Anai H, Ikeda M, Sugimoto M, Akimoto T. Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients. JGH Open 2020;4:722-8. [PMID: 32782962 DOI: 10.1002/jgh3.12325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Bale R, Widmann G, Schullian P, Haidu M, Pall G, Klaus A, Weiss H, Biebl M, Margreiter R. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol. 2012;22:930-937. [PMID: 22071776 DOI: 10.1007/s00330-011-2314-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
57 Imai K, Allard M, Castro Benitez C, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Baba H, Adam R. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. British Journal of Surgery 2017;104:570-9. [DOI: 10.1002/bjs.10447] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
58 Martin RC, Joshi J, Robbins K, Tomalty D, O'Hara R, Tatum C. Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry. J Oncol 2009;2009:539795. [PMID: 19888427 DOI: 10.1155/2009/539795] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
59 de Baere T. Traitement des métastases hépatiques par radiofréquence. Cancer/Radiothérapie 2012;16:339-43. [DOI: 10.1016/j.canrad.2012.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
60 Babawale SN, Jensen TM, Frøkjær JB. Long-term survival following radiofrequency ablation of colorectal liver metastases: A retrospective study. World J Gastrointest Surg 2015; 7(3): 33-38 [PMID: 25848490 DOI: 10.4240/wjgs.v7.i3.33] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
61 Page AJ, Cosgrove D, Pawlik TM. Comparative effectiveness in hepatic malignancies. Cancer Treat Res 2015;164:195-219. [PMID: 25677025 DOI: 10.1007/978-3-319-12553-4_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Terraz S, Cernicanu A, Lepetit-Coiffé M, Viallon M, Salomir R, Mentha G, Becker CD. Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: progress in targeting and preliminary observations with temperature monitoring. Eur Radiol 2010;20:886-97. [PMID: 19760231 DOI: 10.1007/s00330-009-1611-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
63 Jiao LR, Apostolopoulos C, Jacob J, Szydlo R, Johnson N, Tsim N, Habib NA, Coombes RC, Stebbing J. Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol. 2009;27:6160-6165. [PMID: 19884529 DOI: 10.1200/jco.2009.24.5837] [Cited by in Crossref: 67] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
64 Bower MR, Ellis SF, Scoggins CR, McMasters KM, Martin RC. Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol 2011;18:166-73. [PMID: 21222043 DOI: 10.1245/s10434-010-1228-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
65 Gavriilidis P, Roberts KJ, de'Angelis N, Aldrighetti L, Sutcliffe RP. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis. Hepatobiliary Pancreat Dis Int 2021;20:307-14. [PMID: 34127382 DOI: 10.1016/j.hbpd.2021.05.004] [Reference Citation Analysis]
66 Kim KH, Yoon YS, Yu CS, Kim TW, Kim HJ, Kim PN, Ha HK, Kim JC. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc. 2011;81:25-34. [PMID: 22066097 DOI: 10.4174/jkss.2011.81.1.25] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
67 Schullian P, Johnston E, Laimer G, Putzer D, Eberle G, Amann A, Effenberger M, Maglione M, Freund MC, Loizides A, Bale R. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience. Eur Radiol 2021;31:3042-52. [PMID: 33125554 DOI: 10.1007/s00330-020-07409-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
68 Ziemlewicz TJ, Wells SA, Lubner MG, Brace CL, Lee FT Jr, Hinshaw JL. Hepatic Tumor Ablation. Surg Clin North Am 2016;96:315-39. [PMID: 27017867 DOI: 10.1016/j.suc.2015.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
69 van Amerongen MJ, Jenniskens SFM, van den Boezem PB, Fütterer JJ, de Wilt JHW. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. HPB (Oxford) 2017;19:749-56. [PMID: 28687147 DOI: 10.1016/j.hpb.2017.05.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
70 Mahnken AH, Pereira PL, de Baère T. Interventional oncologic approaches to liver metastases. Radiology 2013;266:407-30. [PMID: 23362094 DOI: 10.1148/radiol.12112544] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.0] [Reference Citation Analysis]
71 Jones RP, Jackson R, Dunne DFJ, Malik HZ, Fenwick SW, Poston GJ, Ghaneh P. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases2. British Journal of Surgery 2012;99:477-86. [DOI: 10.1002/bjs.8667] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 8.7] [Reference Citation Analysis]
72 Cacciola A, Parisi S, Tamburella C, Lillo S, Ferini G, Molino L, Iatì G, Pontoriero A, Bottari A, Mazziotti S, Cicero G, Minutoli F, Blandino A, Pergolizzi S. Stereotactic body radiation therapy and radiofrequency ablation for the treatment of liver metastases: How and when? Rep Pract Oncol Radiother 2020;25:299-306. [PMID: 32194349 DOI: 10.1016/j.rpor.2020.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Pathak S, Jones R, Tang JM, Parmar C, Fenwick S, Malik H, Poston G. Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis. 2011;13:e252-e265. [PMID: 21689362 DOI: 10.1111/j.1463-1318.2011.02695.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 11.0] [Reference Citation Analysis]
74 Wells SA, Hinshaw JL, Lubner MG, Ziemlewicz TJ, Brace CL, Lee FT Jr. Liver Ablation: Best Practice. Radiol Clin North Am 2015;53:933-71. [PMID: 26321447 DOI: 10.1016/j.rcl.2015.05.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
75 Lo SS, Moffatt-bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman RD. The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 2011;8:405-16. [DOI: 10.1038/nrclinonc.2011.75] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
76 Luo RG, Gao F, Gu YK, Huang JH, Li CL. Radioablation settings affecting the size of lesions created ex vivo in porcine livers with monopolar perfusion electrodes. Acad Radiol 2010;17:980-4. [PMID: 20599156 DOI: 10.1016/j.acra.2010.03.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Carter S, Martin Ii RC. Drug-eluting bead therapy in primary and metastatic disease of the liver. HPB (Oxford) 2009;11:541-50. [PMID: 20495705 DOI: 10.1111/j.1477-2574.2009.00071.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]